Novel functional cisplatin carrier based on carbon nanotubes–quercetin nanohybrid induces synergistic anticancer activity against neuroblastoma in vitro
- 1 July 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (59) , 31378-31384
Abstract
The synergistic effects of a three-functional hybrid material composed of methacrylic acid (MAA), quercetin (Q) and carbon nanotubes (CNT), with cisplatin (CP) was evaluated in human neuroblastoma cells. A three-functional hybrid material suitable for CP combination therapy was synthesized through the free radical-induced reaction between methacrylic acid, quercetin and carbon nanotubes. Two-functional materials were prepared and fully characterised by coupling CNT and MAA, as well as MAA and Q. A Folin–Ciocalteu assay was used to assess the functionalisation degree expressed as mg of Q per gram of materials and we found to be 2.33 for CNT_PMAA_Q and 2.01 for PMAA_Q. The anticancer activity of CNT_PMAA_Q was shown in human neuroblastoma cells using the Alamar blue cell proliferation assay. Successively, cells were treated with a combination of CP and the nanocomposite showing strong synergistic anticancer effects in neuroblastoma cells. These studies showed that nanoparticle formulations incorporating quercetin and carbon nanotubes are good candidates for CP synergistic treatment against neuroblastoma.Keywords
This publication has 41 references indexed in Scilit:
- Drug-loading capacity and nuclear targeting of multiwalled carbon nanotubes grafted with anionic amphiphilic copolymersInternational Journal of Nanomedicine, 2013
- Molecular Dynamics Study of Cisplatin Release from Carbon Nanotubes Capped by Magnetic NanoparticlesThe Journal of Physical Chemistry C, 2013
- Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapyAdvanced Drug Delivery Reviews, 2011
- Trafficking and Subcellular Localization of Multiwalled Carbon Nanotubes in Plant CellsACS Nano, 2010
- Selective targeting of neuroblastoma tumour‐initiating cells by compounds identified in stem cell‐based small molecule screensEMBO Molecular Medicine, 2010
- Cisplatin filled multiwalled carbon nanotubes – a novel molecular hybrid of anticancer drug containerThe European Physical Journal B, 2010
- Multi-functional nanocarriers to overcome tumor drug resistanceCancer Treatment Reviews, 2008
- Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing DeviceJournal of the American Chemical Society, 2008
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialThe Lancet Oncology, 2008
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007